Public market insider buying at Profound Medical (PRN)
Public market insider buying at Profound Medical (T:PRN)
Updated Monday May 16, 2022 04:24 AM EDT
Arun Menawat, CEO and Director, acquired 30,516 Common Shares on a direct ownership basis at a price of $6.655USD on May 12th, 2022. This represents a $264,793 investment into the company's shares and an account share holdings change of 8.8%. Ken Knudson, a Senior Officer, acquired 8,000 Common Shares on a direct ownership basis at a price of $7.066USD on May 12th, 2022. This represents a $73,704 investment into the company's shares and an account share holdings change of greater than 100%.
Profound Medical is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.
Headlines: May 16, 2022
PRN Insider Holdings Chart
Issuer details as of May 16, 2022 4:24 ET
Latest Price
9.01
1 Day Change
5.63%
52 Week High
23.67
52 Week Low
8
QMV ($Mils)
187,223,448
Issuer website: https://profoundmedical.com/